Eric Konofal is a co-founder of NLS Pharma and the head of drug discovery. Eric was appointed to the NLS Pharma Board of Directors in December 2015. He is a well known medical opinion leader in the field of child psychopathology and adolescent and pediatric sleep disorders. He’s involved in clinical research since 1999 and has published over 50 peer-reviewed papers and is an expert consultant for the French National Agency of Medicine and Health Products (ANSM) and for the European Medicines Agency (EMA). Eric received his M.D. and Ph.D. from UCMP/Paris and is a board certified neurologist.